TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
1,092 |
| Financial expenses |
48
|
251
|
992 |
| Earnings before taxes |
-965
|
-30,569
|
-50,234 |
| EBITDA |
-917
|
-30,509
|
-49,340 |
| Total assets |
821
|
8,192
|
17,784 |
| Current assets |
554
|
4,290
|
12,809 |
| Current liabilities |
718
|
6,419
|
15,314 |
| Equity capital |
103
|
1,773
|
2,470 |
| - share capital |
21
|
243
|
243 |
| Employees (average) |
1
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
12.5%
|
21.6%
|
13.9% |
| Turnover per employee |
0
|
0
|
546 |
| Profit as a percentage of turnover | -4600.2% | ||
| Return on assets (ROA) |
-111.7%
|
-370.1%
|
-276.9% |
| Current ratio |
77.2%
|
66.8%
|
83.6% |
| Return on equity (ROE) |
-936.9%
|
-1724.1%
|
-2033.8% |
| Change turnover |
0
|
-1,096
|
1,092 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-50%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.